Videos de Experimentos Relacionados
Ghrelin tiene hambre y se pone hambriento.
Jonathan Pinkney1, Gareth Williams
1University of Liverpool, Diabetes and Endocrinology Research Group, Department of Medicine, Clinical Sciences Centre, University Hospital Aintree, L9 7AL, Liverpool, UK. j.pinkney@liverpool.ac.uk
Lancet (London, England)
|April 30, 2002
Resumen
No abstract available in PubMed .
Videos de Conceptos Relacionados
También podría leer
Artículos Relacionados
Artículos vinculados a este trabajo por autores compartidos, revista y gráfico de citas.
Ordenar por
Same author
Erratum: "Thermal and chemical control of emission and excited-state dynamics in non-(TMS)3P-derived InP quantum dots" [J. Chem. Phys. 164, 144702 (2026)].
The Journal of chemical physics·2026
Same author
Retrospective case-control study of pre-diagnosis observational and prescription data in Parkinson's disease.
Scientific reports·2026
Same author
Thermal and chemical control of emission and excited-state dynamics in non-(TMS)3P-derived InP quantum dots.
The Journal of chemical physics·2026
Same author
Logic model development through a feasibility RCT for a group-based weight management programme.
BMJ open·2026
Same author
Optimization of a group-based intervention for people living with severe obesity (PROGROUP): Understanding fidelity to delivery and the patient experience.
British journal of health psychology·2026
Same author
Training Healthcare Professionals to Deliver a Group-Based Intervention for People Living With Severe Obesity: Lessons From the PROGROUP Feasibility Trial.
Journal of human nutrition and dietetics : the official journal of the British Dietetic Association·2026
Same journal
Assisted dying and the silencing of medicine's next generation.
Lancet (London, England)·2026
Same journal
Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.
Lancet (London, England)·2026
Same journal
Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.
Lancet (London, England)·2026
Same journal
[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.
Lancet (London, England)·2026
Same journal
Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.
Lancet (London, England)·2026